SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001047469-18-003949
Filing Date
2018-05-22
Accepted
2018-05-22 06:14:17
Documents
4
Period of Report
2018-06-20
Effectiveness Date
2018-05-22

Document Format Files

Seq Description Document Type Size
1 DEF 14A a2235810zdef14a.htm DEF 14A 694347
2 G30932BGI001.GIF g30932bgi001.gif GRAPHIC 197542
3 G30932BGI002.GIF g30932bgi002.gif GRAPHIC 96600
4 G599137.JPG g599137.jpg GRAPHIC 31780
  Complete submission text file 0001047469-18-003949.txt   1144584
Mailing Address 167 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 167 SIDNEY STREET CAMBRIDGE MA 02139 6176795500
IDERA PHARMACEUTICALS, INC. (Filer) CIK: 0000861838 (see all company filings)

IRS No.: 043072298 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-31918 | Film No.: 18851250
SIC: 2836 Biological Products, (No Diagnostic Substances)